As of 2026-01-07, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (131.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.35 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -1892.5%.
The range of the Relative Valuation is (132.30) - (130.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.9x - 17.8x | 12.4x |
| Forward P/E multiples | 18.1x - 29.3x | 23.7x |
| Fair Price | (132.30) - (130.10) | (131.75) |
| Upside | -1899.9% - -1870.1% | -1892.5% |
| Date | P/E |
| 2026-01-06 | -1.01 |
| 2026-01-05 | -1.01 |
| 2026-01-02 | -0.98 |
| 2025-12-31 | -1.01 |
| 2025-12-30 | -1.00 |
| 2025-12-29 | -1.00 |
| 2025-12-26 | -1.02 |
| 2025-12-24 | -1.02 |
| 2025-12-23 | -1.02 |
| 2025-12-22 | -0.99 |
| 2025-12-19 | -0.95 |
| 2025-12-18 | -0.87 |
| 2025-12-17 | -0.82 |
| 2025-12-16 | -0.87 |
| 2025-12-15 | -0.92 |
| 2025-12-12 | -0.95 |
| 2025-12-11 | -0.96 |
| 2025-12-10 | -0.89 |
| 2025-12-09 | -0.87 |
| 2025-12-08 | -0.81 |
| 2025-12-05 | -0.79 |
| 2025-12-04 | -0.81 |
| 2025-12-03 | -0.75 |
| 2025-12-02 | -0.73 |
| 2025-12-01 | -0.79 |
| 2025-11-28 | -0.77 |
| 2025-11-26 | -0.76 |
| 2025-11-25 | -0.75 |
| 2025-11-24 | -0.76 |
| 2025-11-21 | -0.81 |
| 2025-11-20 | -0.79 |
| 2025-11-19 | -0.82 |
| 2025-11-18 | -0.85 |
| 2025-11-17 | -0.79 |
| 2025-11-14 | -0.78 |
| 2025-11-13 | -0.75 |
| 2025-11-12 | -0.76 |
| 2025-11-11 | -0.75 |
| 2025-11-10 | -0.74 |
| 2025-11-07 | -0.71 |
| 2025-11-06 | -0.71 |
| 2025-11-05 | -0.73 |
| 2025-11-04 | -0.77 |
| 2025-11-03 | -0.83 |
| 2025-10-31 | -0.79 |
| 2025-10-30 | -0.82 |
| 2025-10-29 | -0.83 |
| 2025-10-28 | -0.87 |
| 2025-10-27 | -0.88 |
| 2025-10-24 | -0.87 |